Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 6,712 | 5,609 | 4,310 | 3,516 | 5,582 |
| Cost of Goods | 1,108 | 554 | 413 | 517 | 435 |
| Gross Profit | 5,604 | 5,055 | 3,897 | 2,999 | 5,147 |
| Operating Expenses | 99,412 | 96,222 | 103,482 | 94,606 | 103,222 |
| Operating Income | -93,700 | -90,613 | -99,172 | -91,090 | -97,640 |
| Other Income | 9,894 | 9,595 | 135,698 | 9,343 | 5,834 |
| Pre-tax Income | -83,806 | -81,018 | 36,526 | -81,747 | -91,806 |
| Net Income Continuous | -83,806 | -81,018 | 36,526 | -81,747 | -91,806 |
| Net Income | $-83,806 | $-81,018 | $36,526 | $-81,747 | $-91,806 |
| EPS Basic Total Ops | -1.51 | -1.47 | 0.68 | -1.49 | -1.68 |
| EPS Basic Continuous Ops | -1.51 | -1.47 | 0.67 | -1.49 | -1.68 |
| EPS Diluted Total Ops | -1.51 | -1.47 | 0.68 | -1.49 | -1.68 |
| EPS Diluted Continuous Ops | -1.51 | -1.47 | 0.67 | -1.49 | -1.68 |
| EPS Diluted Before Non-Recurring Items | -1.51 | -1.47 | 0.67 | N/A | N/A |
| EBITDA(a) | $-94,855 | $-91,599 | $-99,277 | $-89,770 | $-95,117 |